Limited digestion of rat cerebellum microsomal vesicles with trypsin resulted in the proteolysis of the 240 kDa inositol 1,4,5-trisphosphate receptor (IP3R) and the formation of a 94 kDa species that remained membrane-bound and retained immunoreactivity to an antibody raised against the C-terminal sequence of this protein. 
INTRODUCTION
Intracellular Ca2+ mobilization in response to many hormones, growth factors and neurotransmitters is mediated by the release of inositol 1,4,5-trisphosphate (IP3) [1] . This molecule interacts with a specific receptor glycoprotein (IP3R) that has been purified from several sources [2] [3] [4] [5] . The IP3R is tetrameric, with a subunit molecular mass on SDS/PAGE of 240-260 kDa. Functional reconstitution of the purified protein in liposomes [6, 7] and planar lipid bilayers [8] indicates that the IP3R is itself a ligandgated Ca2+ channel.
Large amounts of the type-I IP3R protein are found in the Purkinje neuron of the cerebellum [9] . The full-length cDNA encoding the type-I IP3R isoform has been cloned from mouse [10] , rat [11] , Drosophila [12] and Xenopus [13] . Mutational analysis [14, 15] and experiments with photo-activatable IP3 analogues [16] have suggested that the ligand binding domain of the receptor is located in the N-terminal 650 amino acids. The major portion of the receptor faces the cytoplasmic space and is believed to contain a regulatory domain, including phosphorylation sites and sites for ATP binding. In vitro, the brain IP3R is a substrate for protein kinase A (A-kinase) [17] , protein kinase C [18] and Ca2+/calmodulin-dependent protein kinase II [18] . The location of the phosphorylation sites for A-kinase have been mapped to serine residues 1589 and 1755 [19] .
There is growing evidence that multiple forms of the IP3R may exist in different tissues. Two alternatively spliced variants of the IP3R have been reported. One has a 15-amino-acid deletion in the N-terminal region and has been detected in brain [11, 20] . The other, which appears to be the predominant form in vas deferens and fetal brain, has a 40-amino-acid deletion between the Akinase phosphorylation sites [21] . Recently, two additional IP3 site at serine-1755 and the first transmembrane segment of the IP3R. A second antibody raised to amino acids 401-414 in the Nterminal region of the receptor recognizes a 68 kDa fragment released into the soluble fraction after trypsin treatment. The time course of release of the 68 kDa fragment was correlated with the appearance of soluble binding sites, and the fragment was bound by IP3-Affigel resin. A large proportion of the 68 kDa fragment remained associated with the membrane fraction and could be specifically immunoprecipitated from detergent extracts of digested membranes by anti-C-terminus antibody. Our results provide experimental evidence to further localize the ligand binding domain and suggest that regions of the N-terminus and C-terminus may be non-covalently associated.
receptors have been cloned. The type-II IP3R is predominantly found in brain, lacks the A-kinase sites and has 65 % sequence identity with the type-I IP3R [14] . The type-III IP3R is found predominantly in pancreatic islets, kidney and the gastrointestinal tract [22, 23] . This isoform has consensus sites for several protein kinases and has 62 % sequence identity with the type-I receptor. Partial sequence data for a fourth form of IP3R have also been reported [24] .
The C-terminal region of the protein contains several stretches of hydrophobic residues that could potentially span the membrane. However, the transmembrane topology of the receptor is controversial [25] . Based on hydropathy analysis, models with six [12, 26, 27] , seven [10] , eight [11, 14, 22] or nine [10] transmembrane loops have been proposed. In an effort to obtain further information on the domain structure and transmembrane topology of this protein, we have used limited proteolysis of the IP3R in brain microsomal membranes and anti-IP3R antibody, ligand and lectin binding to study the proteolytic fragments. We provide experimental evidence that further localizes the ligand binding domain of the receptor and suggests that portions of the N-terminus and C-terminus may be non-covalently associated. Our experimental results are also incompatible with some models of IP3R topology.
MATERIALS AND METHODS Proteolysis of membranes
Microsomal membranes were prepared from rat cerebellum homogenates by differential centrifugation as described previously [28] . Routinely, digestion of membranes was carried out at 1 mg of protein/ml in trypsin treatment buffer containing 120 mM KCl, 20 mM Tris/HC1 (pH 7.8), 1 mM EDTA, 1 mM dithiothreitol (DTT) and 10-20,g/ml trypsin (Boehringer Mannheim). After incubation at room temperature for 5 min, a 10-fold excess of soybean trypsin inhibitor (Sigma Chemical Co.) and 1 mM PMSF were added. Membranes and soluble fractions were recovered by centrifugation at 1000OOg on a Beckman Benchtop ultracentrifuge using the TLA 100 rotor. When required, the IP3Rs in control or trypsin-digested membranes were solubilized (1 mg of protein/ml) on ice for 30 min using 1 % (w/v) Triton X-100 and a buffer containing 0.32 M sucrose, 20 mM Tris/HCl, pH 7.8, 1 mM DTT and 0.5 mM PMSF (solubilization buffer). This buffer was additionally supplemented with 5 1l/ml of a proteinase-inhibitor cocktail stock solution which contained aprotinin (0.6 mg/ml), pepstatin A (0.45 mg/ml), leupeptin (0.3 mg/ml), soybean trypsin inhibitor (0.2 mg/ml) and antipain (0.45 mg/ml). Detergent extracts were obtained after centrifugation for 45 min at 100000 g.
Immunoprecipitation and Immunoblotting of the IP3R
A polyclonal antibody was raised in a rabbit to a synthesized peptide corresponding to the C-terminus of the type-I IP3R (residues 2731-2749; [10, 11] ) which was coupled via an additional N-terminal cysteine to keyhole limpet haemocyanin using the bifunctional cross-linking agent N-succinylimidyl 3-(2-pyridyldithio)propionate [29] . The characteristics of this antibody and experimental conditions for immunoprecipitation and immunoblotting have been described [30] . Briefly, immunoprecipitation was carried out in 100 ,ug aliquots of Triton X-100-solubilized extracts in a final volume of 1 ml of solubilization buffer supplemented with 0.1 % SDS. The samples were incubated for 2 h with 100,g of immune serum, and immune complexes were precipitated after a further 2 h incubation with 100,1 of 20 % (v/v) Protein A-Sepharose. After washing three times in immunoprecipitation buffer, the beads were resuspended in 50,l of SDS gel sample buffer boiled for 5 min, and samples were analysed on SDS/polyacrylamide gels. Separated proteins were transferred to nitrocellulose sheets and processed with antibodies using the following sequential steps interposed by three 5 min washes with Tris-buffered saline containing 0.05 % (v/v) Tween-20 (TTBS): blocking for 2 h with 3 % (w/v) BSA in TTBS; incubation for 1 h with a 1:500 dilution of immune or preimmune serum; incubation for 1 h with a 1: 3000 dilution of biotinylated goat anti-rabbit IgG (Vector Labs); incubation for 30 min with a 1:3000 dilution of horseradish peroxidase (HRP)-avidin D (Vector Labs) and colour development with 4-chloro-1-naphthol as described in [31] . In some experiments immunoreactive bands were detected with 125I-labelled goat anti-rabbit IgG (ICN Radiochemicals) or an enhanced chemiluminescence kit (Amersham Corp.).
A second anti-IP3R antibody used in this study (referred to as KEEK-Ab) was raised against a peptide corresponding to amino acids 401-414 of the type-I receptor. The procedures used for coupling and preparation of the antibody were the same as described for the anti-C-terminus antibody. The antibody was purified on a Protein A-agarose column [31] and then affinitypurified using the peptide coupled to EMPHAZE beads as described by the manufacturer (Pierce Chemical Co.). For immunoblotting the nitrocellulose sheets were blocked in 10 % non-fat milk in TTBS for 4 h and incubated overnight in a 1: 100 dilution of the affinity-purified antibody. After a 30 min incubation with a 1:5000 dilution of HRP-conjugated donkey anti-rabbit Ab (Amersham) the blots were developed using an enhanced chemiluminescence kit.
LecUn blotting and digestion with N-glycopeptidase F Nitrocellulose sheets containing transferred proteins were blocked for 4 h in 0.5 % (w/v) casein dissolved in Tris-buffered saline (TBS) and then incubated overnight with a 20,ug/ml solution of biotinylated concanavalin A (ConA; Sigma Chemical Co.) in TBS containing 1 mM each of CaCl2, MgCl2 and MnCl2. After 3 x 5 min washes in TBS, the sheets were incubated for 2 h with a 1:1600 dilution of HRP-coupled avidin D and the colour reaction was carried out as described for immunoblotting. NGlycopeptidase F digestion was carried out on IP3R immunoprecipitate from detergent extracts of control or trypsin-treated membranes. The Protein A-Sepharose beads obtained from immunoprecipitating 100 ,ug of detergent extract protein were washed once in 10 mM sodium phosphate buffer (pH 8.0) containing 1 % Nonidet P-40, resuspended in 15 ,1 of 0.5 % SDS and 0.1 M ,J-mercaptoethanol and boiled for 3 min. A further 30 ,ul of a buffer containing 2 % Nonidet P-40, 20 mM sodium phosphate (pH 8.0), 20 mM EDTA, 10 ,ul/ml proteinaseinhibitor cocktail and 14 units/ml N-glycopeptidase F (Genzyme Corporation, Boston, MA, U.S.A.) was added. The samples were incubated for 18 h at 37°C, quenched with SDS sample buffer and processed on SDS/PAGE (10 % gels) for lectin and immuno-blotting.
Measurement of [3H]IP3 binding
Binding of [3H]IP3 to microsomal membranes was measured routinely using labelled ligand at a concentration of 3 nM (17 Ci/mmol; New England Nuclear) and a filtration assay as described previously [28] . Binding of [3H]IP3 to solubilized extracts was measured using a poly(ethylene glycol) precipitation assay. Aliquots of the extract were incubated at 4°C in a final volume of 120 #1 in a buffer containing 120 mM KCI, 20 mM Tris/HCl (pH 8.1), 1 mM EDTA and 3 nM [3H]IP3. After 10 min, 50 ,ul of 10 mg/ml y-globulin and 0.83 ml of 15 % (w/v) poly-(ethylene glycol) (average molecular mass 8 kDa) were added and the incubation was continued for a further 30 min. Bound receptors were precipitated by centrifugation at 13000 g for 10 min. The pellets were solubilized overnight in 0.5 ml of 0.1 M NaOH and radioactivity was counted in Ecolume (ICN).
Affigel-P3 resin chromatography
The affigel-IP3 resin was prepared as described [32] and was kindly provided by Dr. Glenn Prestwich (State University of New York, Stony Brook, NY, U.S.A.). Microsomal membranes (5-7 mg) were treated with trypsin, and membrane and soluble fractions were recovered as described above. The membrane pellet was resuspended in 0.1 M Na2Co3 (pH Il) and recentrifuged at 100000g. The supernatant was neutralized and combined with the original soluble fraction obtained after trypsin treatment. The pooled fractions were mixed with 2 ml of packed Affigel-IP3 resin previously equilibrated in trypsin treatment buffer. After shaking for 1 h at room temperature, the beads were recovered by centrifugation and washed twice in trypsin treatment buffer. Bound fragments were eluted from the beads by a 1 h incubation with 2 ml of trypsin treatment buffer containing an additional 0.5 M KCI. The beads were centrifuged and eluted again with a further 2 ml of the same buffer containing an additional 10 ,uM 'P3. The two eluates were concentrated on a Centricon-30 (Amicon Corp.), supplemented with 20 ,g of yglobulin as a carrier, and the entire fraction was precipitated with trichloroacetic acid.
RESULTS

Tryptic fragments recognized by anti-C-terminus antibody
Figure l(a) shows that the C-terminal peptide IP3R antibody recognized a single 240 kDa polypeptide that is entirely membrane-bound and represents the active IP3R present in these membranes. Cleavage with increasing concentrations of trypsin produced a series of fragments associated with a decline in the amount of the 240 kDa species. After 15 min of incubation of the membranes with 1 ,ug/ml trypsin, five membrane-bound fragments retaining immunoreactivity were reproducibly observed. The smallest of these had a molecular mass of 94.0 + 3.4 kDa (mean+S.E.M. of four determinations). As the trypsin concentration was raised to 5 ,Ig/ml, this species predominated, and at 10 ,ug/ml it remained the only tryptic fragment visible on the immunoblots. The 94 kDa species was formed within 1 min of incubation with 10 ,Ig/ml trypsin, was stable for at least 5 min and was then progressively hydrolysed (Figure lb) . Smaller immunoreactive fragments derived from the hydrolysis of the 94 kDa species were not detected on gel systems that resolved polypeptides having molecular masses greater than 18 kDa (results not shown). These data indicate that the 94 kDa species represents the smallest membrane-bound tryptic fragment of the IP3R retaining the C-terminal epitope recognized by the antibody. (Figure 2 ). In agreement with previous studies [17] , the IP3R in untreated cerebellum micro- somes was readily phosphorylated by A-kinase. However, treatment with trypsin generated a 94 kDa fragment that did not retain radio activity and must therefore be missing the phosphorylation site. It is known that serine-1755 is preferentially phosphorylated by A-kinase [19] . Our data would suggest that stepwise proteolysis eventually cleaves the receptor somewhere between serine-1755 and the first transmembrane loop to generate the 94 kDa fragment.
The IP3R purified from rat cerebellum is known to be glycosylated, based on the observations that the protein adheres to ConA-Sepharose columns [2] . In order to investigate whether the 94 kDa tryptic fragment retains the sugars present in the native receptor, Western blots containing the immuno- Mutational analysis of the IP3R has already established that the ligand binding domain is located within the N-terminal 650 amino acids present in the large cytoplasmic portion of the receptor [14, 15] . Our data would indicate that this portion is released from the microsomal membrane upon limited proteolysis in a form that retains ligand binding. The 94 kDa species would represent the portion of the receptor protein, missing the ligand binding domain, but retaining transmembrane loops and associated C-terminus. In order to recognize soluble putative ligand binding receptor fragments, we utilized a second antibody (KEEK-Ab) raised to amino acids 401-414 of the rat type-I IP3R sequence. Figure 5(a) shows the result of immunoblotting soluble and pellet fractions prepared from the membranes at various times after trypsin treatment. KEEK-Ab recognized a 68 kDa polypeptide (67.6 + 1.3 kDa; n = 4) released by trypsin treatment into the soluble fraction (Figure 5a ). Several trypsin-generated polypeptides retaining the KEEK epitope, including the 68 kDa band, were also found associated with the pellet fraction ( Figure  5b ). This figure also shows the generation of a characteristic set of larger immunoreactive polypeptides that represent intermediate digestion products. None of these polypeptides were immunoreactive when KEEK-Ab was preincubated with the peptide corresponding to amino acids 401-414 (results not shown). In some experiments the 68 kDa band appeared as a doublet of a major and a minor band (cf. Figure 7) , and there was also experimental variation in the exact time course of the appearance of soluble binding sites. However, the appearance of soluble ligand binding sites and soluble immunoreactive 68 kDa fragment were temporally correlated when both parameters were measured in the same experiment (e.g. Figures 4 and 5a) .
Interaction of the N-terminal segment with the C-terminus Figure 5 (b) shows that a significant proportion of the 68 kDa KEEK-immunoreactive polypeptide remains associated with the membrane after trypsin digestion. The nature of the interaction of this N-terminal fragment with the membrane has been further investigated in the experiments shown in Figures 6 and 7 . Treatment of microsomal vesicles with 0.1 M Na2CO3 (pH 11.0) has been established to release peripheral and intraluminal proteins, whereas integral membrane proteins remain in the pellet fraction [33] . Incubation of trypsin-treated membranes with Na2CO3 led to the complete removal of the 68 kDa fragment from the membrane ( Figure 6, lanes 1 versus 4) and appearance of the 68 kDa polypeptide in the Na2CO3 supernatant ( Figure 6 , lanes 3 versus 6). The 94 kDa tryptic fragment, recognized by the C-terminal antibody, remained in the pellet fraction after Na2CO3 treatment (results not shown and Figure 7 , lane 3). These data suggest that the N-terminal 68 kDa fragment is peripherally associated with the membrane. The experimental data in Figures  4 and 5 show that the membranes rapidly lose binding activity Triton X-100. Detergent extracts were immunoprecipitated with C-terminal antibody as described in the Materials and methods section. One set of membranes was treated with Na2CO3 as described in Figure 6 prior to solubilization and immunoprecipitation (lanes 3 and 6). Equal aliquots of the washed immunoprecipitates were run on SDS/10% PAGE, transferred to nitrocellulose and immunoblotted with either C-terminal antibody (lanes 1-3) or KEEK-Ab (lanes 4-7). Lane 7 contains the trichloroacetic acid-precipitated protein obtained from the supernatant of Na2CO3-treated trypsinized membranes.
after limited proteolysis and yet contain bound 68 kDa fragment. The fraction released by Na2CO3 washing of trypsin-treated membranes contains ligand binding activity (results not shown). This suggests that the conformation of the membrane-attached 68 kDa fragment generated after trypsin addition is different from that of the soluble 68 kDa fragment, and that the membrane-attached form has low ligand binding activity. The peripheral membrane associated of the 68 kDa fragment does not appear to involve disulphide bonds, because the trypsin digestion medium contained 1 mM DTT and the migration of the immunoreactive fragments in the membranes was not different when analysed on non-reducing SDS/PAGE (results not shown). We tested the hypothesis that the interaction of the Nterminal 68 kDa fragment with the membrane may involve an association with the C-terminal portion of the receptor. This was done by using the anti-C-terminus antibody to immunoprecipitate the receptor fragments from Triton X-100 extracts of undigested and digested membranes (Figure 7) . The immunoprecipitates were immunoblotted on both C-terminal and KEEK antibodies. As shown previously, the C-terminal antibody recognized a predominant band of 94 kDa generated by trypsin treatment ( Figure 7, lane 2) . However, the C-terminal antibody also immunoprecipitated a 68 kDa band recognized by the KEEK antibody and having the same mobility as the KEEK immunoreactive fragment found in Na2CO, washes of trypsin-treated membranes ( Figure 7, lane 5 and 7) . Pretreatment of the membranes with Na2C after trypsin digestion did not alter the immunoprecipitation of the 94 kDa fragment, but completely prevented the immunoprecipitation of the 68 kDa KEEKreactive fragment (lanes 3 and 6) . The converse experiment, in which KEEK-Ab is used to immunoprecipitate the C-terminal fragment, was not possible, as KEEK-Ab failed to immunoprecipitate the intact IP3R from Triton X-100 extracts. Binding of the 68 kDa fragment of Affiel-11P3 resin
To obtain additional evidence for the identity of the soluble ligand binding domain, we made use of an affinity matrix containing IP3 attached to an Affigel resin that has previously been utilized for the purification of the cerebellar IP3R [32] . The soluble fraction obtained after trypsin treatment was pooled with the Na2CO3 wash of trypsin-treated membranes and incubated with the Affigel-IP3 resin. The beads were washed and then eluted using 0.5 M KCl alone or in combination with 10 ,M IP3. Figure 8 shows [13] and Drosophila [12] cDNAs has led to a six-transmembrane-loop model [26] . Our data would be consistent with this revised model, which places two N-glycosylation sites between putative loops 5 and 6 within the endoplasmic reticulum lumen. Site-directed mutagenesis experiments suggesting that both sites in the mouse type-I IP3R are glycosylated have been reported recently [27] . Limited digestion of cerebellar membranes with trypsin released [3H]IP3 binding sites into the soluble fraction (Figure 4) . In order to follow the release of some of the soluble N-terminal fragments, we raised an antibody to the peptide sequence corresponding to amino acids 401-414 of the type-I IP3R. This KEEK-Ab did not recognize the native protein and was incapable of immunoprecipitating the receptor from detergent extracts of cerebellum microsomal membranes (results not shown). However, the antibody recognized intact and proteolytic receptor fragments on Western blots. This suggests that in the native receptor the peptide epitope may be hidden by protein folding and association with other parts of the receptor. The KEEK-Ab recognized a 68 kDa tryptic fragment released into the soluble fraction. Three lines of evidence suggest that the immunoreactive 68 kDa fragment encompasses the ligand binding site of the receptor. First, the time course of the appearance of the 68 kDa fragment correlated with the time course of the appearance of soluble [3H]IP3 binding sites. Secondly, the 68 kDa fragment bound to immobilized IP3 and could be eluted from the affinity matrix by added IP3. Thirdly, the 68 kDa fragment was recognized on immunoblots by a polyclonal antibody raised to amino acids 467-484 (results not shown). This stretch of sequence within the receptor has previously been shown to be involved in binding to photolabelled IP3 [16] . Our data are consistent with previous studies showing that the ligand binding site can be independently expressed as soluble recombinant proteins encoding the N-terminal 736 [15] or 788 [35] amino acids of the receptor.
We have found that the major portion of the immunoreactive fragments formed from the receptor after limited trypsin treatment is not released into the soluble fraction but remains tightly associated with the membranes. Attachment of the KEEKimmunoreactive fragments was disrupted by treatment of the membranes with Na2CO3, whereas a detergent was required for solubilization of the 94 kDa C-terminal trypsin fragment. The 68 kDa KEEK-immunoreactive fragment was specifically immunoprecipitated by antibody directed at the receptor's Cterminus, suggesting that the C-terminal transmembrane domain and a segment of the N-terminal domain are held together by non-covalent interactions. This does not necessarily require that the two domains are in direct contact, since it is also feasible that both domains interact non-covalently with a third interposed fragment which is not recognized by either of the two IP3R antibodies. In a recent study mapping the tryptic fragments formed from digestion of the ryanodine receptor in sarcoplasmic reticulum vesicles, it was also noted that none of the immunoreactive fragments were released into the soluble fraction [36] .
Some of the fragments derived from the N-terminal region could be released by Na2CO3 treatment. Both the peripherally associated and transmembrane segments were found to co-migrate at the bottom of sucrose-density gradients. On this basis, it was suggested that the association of N-terminal and C-terminal fragments reflects the involvement of both regions in oligomerization of the ryanodine receptor. Since oligomerization of the IP3R has been proposed to involve only the transmembrane domain [35] , it was predicted that the type of domain interactions observed in the ryanodine receptor would not be observed for the IP3R. However, the behaviour of the IP3R appears similar to that of the ryanodine receptor, suggesting that the interactions between widely separated domains in both of these Ca2+ channels may serve some function other than oligomerization of subunits.
The functional significance of interactions between receptor domains is presently not clear, but three possibilities should be considered. First, folding of the receptor may bring the ligand binding and channel domains into close proximity, and this would clearly have important implications for how the channel is gated by IP3. A monoclonal antibody (18A10) recognizing an epitope at the C-terminus of IP3R has been shown to competitively inhibit IP3-mediated Ca2+ release and to stimulate IP3 binding [37] . This effect of 18A10 on ligand binding has been viewed as the result of a conformational change in the protein occurring upon antibody binding to the C-terminus. The possibility that the N-terminal ligand binding domain may be in close proximity to the 18A10 epitope lends further support to this explanation.
Another possibility is that the association between N-and Cterminal domains has some structural significance. It has been reported that stacks of endoplasmic reticulum cisternae seen in cerebellar Purkinje cells or COS cells overexpressing IP3R contain crystalline arrays of IP3R [38, 39] . The gaps between adjacent stacked membranes contain bridge structures thought to be made of' head-to-head' contacts between the N-terminal receptor domains. However, 'head to-tail' interactions between receptors bridging the cisternal space, or lateral interactions between adjacent receptors, may also play a role in maintaining the structure of endoplasmic reticulum stacks. Finally, it cannot be excluded that the peripheral association of N-terminal tryptic fragments with the membrane reflects non-specific interactions occurring after the initiation of proteolysis. However, this seems less likely in view of the finding that the 68 kDa KEEKimmunoreactive fragment is specifically immunoprecipitated by antibody directed to the receptor's C-terminus. Further work with cross-linking agents should help to address this issue.
The cytoplasmic domain of the IP3R expressed in COS cells has been shown to undergo a large conformational change upon binding IP3 [35] . This change corresponded to an apparent decrease of 50 kDa in molecular mass as measured by mobility in a gel filtration column. These data have led to a model in which the ligand binding domain is viewed as being widely separated from the channel-forming transmembrane domain at the Cterminus, with the large ligand-induced conformational change being required for channel gating [35] . If such large conformational changes also occur in the full-length receptor in its native membrane environment, it would be anticipated that IP3 would alter the surface accessibility of one or more proteinase-accessible sites. Using trypsin, chymotrypsin, endoproteinase glu-C or proteinase-K and either the C-terminal antibody or KEEK-Ab as probes, we have been unable to detect any change in cleavage pattern when cerebellum microsomes are preincubated with IP3 (results not shown). This would suggest that any conformational changes mediated by IP3 in the native protein may be considerably more subtle than those observed in truncated soluble receptor constructs. Our data would also suggest that the current IP3R spatial domain model, which does not envisage any intramolecular non-covalent interactions between widely separate domains, requires re-evaluation.
